Cannabis
Aquarius AI Announces Proposed Shares for Debt Transaction & Postponement of Annual General Meeting
Vancouver, British Columbia–(Newsfile Corp. – June 2, 2020) – Aquarius AI Inc. (TSXV: AQUA) (FSE: 4G5) (“AQUA”, or the “Company”) announces that the Company has agreed to issue 11,195,512 common shares of the Company (the “Settlement Shares“) at a price of C$0.05 per share in settlement of outstanding debts totaling C$1,475,573 (the “Debt“) owing to arm’s length parties. The Company is proposing to issue the Settlement Shares in order to preserve cash to fund future operations.
By issuing the Settlement Shares, the Debt will be definitively extinguished.
The shares for debt settlement was carried out pursuant to prospectus exemptions of applicable securities laws. The issuance of the Settlement Shares are subject to the approval of the TSX Venture Exchange.
The Company also announces the postponement of its annual general meeting of shareholders (“Meeting“), originally anticipated to take place prior to July 26, 2020, to an as-yet undetermined date. The Company has postponed the Meeting as and until the Company explores and evaluates various corporate changes that are intended to maximize AQUA’s efficiency. The Meeting will be rescheduled for a date prior to January 26, 2021 in accordance with an extension granted by the British Columbia Registrar. Once the Meeting is scheduled, the Company will deliver to its shareholders a notice of Meeting, an information circular and proxy materials in connection therewith.
For further information:
Aquarius AI Inc.
Melissa Adams
[email protected]
(604) 265-7511
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements:
Certain disclosure in this release, including statements regarding the proposed debt settlement and the Meeting, may constitute “forward-looking information” within the meaning of Canadian securities legislation. In making the forward-looking statements in this release, the Company has applied certain factors and assumptions that the Company believes are reasonable, including that the Company will obtain the necessary regulatory approvals for the debt settlement and the Company will be in a position to hold the Meeting before January 26, 2021. However, the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such uncertainties and risks include, among others, delays in obtaining or inability to obtain required regulatory approvals for the debt settlement, the Company not being in a position to hold the Meeting before January 26, 2021 and changes in the Company’s plans. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/57011
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace